Previous 10 | Next 10 |
home / stock / mset:cc / mset:cc news
TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) , a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications ...
TORONTO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") , a drug discovery and development company focused on creating novel, optimized, next-generation psychedelic and non-psychedelic medications to ...
TORONTO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) , a drug discovery and development company focused on creating novel, optimized, next-generation psychedelic and non-...
TORONTO, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") , a drug discovery and development company focused on creating novel, optimized, next-generation psychedelic and non-psychedelic medications to t...
TORONTO, July 06, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") , a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurologic...
TORONTO, June 29, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) , a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic-i...
TORONTO, June 22, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) , a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic m...
TORONTO, June 10, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") , a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurologic...
TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") , a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurologic...
TORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") , a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurologica...
News, Short Squeeze, Breakout and More Instantly...
Canadian Investment Regulatory Organization Trading Halt - MSET Canada NewsWire VANCOUVER, BC , Oct. 27, 2023 /CNW/ - The following issues have been halted by CIRO: Company: Mindset Pharma Inc CSE Symbol: MSET All Issues: Yes Reason: Pending News ...
Toronto, Ontario--(Newsfile Corp. - October 27, 2023) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce that further to its press releases of August 31, 2023, September 22, 2023 and October 19, 2023, Otsuka Pharmaceutical Co., Lt...
Toronto, Ontario--(Newsfile Corp. - October 25, 2023) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce that further to its press releases of August 31, 2023, September 22, 2023, October 5, 2023, and October 19, 2023, the Company...